Chloroform-induced cytotoxicity and regenerative cell proliferation in the kidneys and liver of BDF1 mice

Cancer Letters

Volumn 108, Issue 2, 1996, Pages 225-231

  Templin, Michael V ^a   Jamison, Keith C ^a   Sprankle, Catherine S ^a   Wolf, Douglas C ^a   Wong, Brian A ^a   Butterworth, Byron E ^a  

^a CIIT CENTERS FOR HEALTH RESEARCH   (United States)

Author keywords

BDF1 mice; Cell proliferation; Chloroform

Indexed keywords

BROXURIDINE; CHLOROFORM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOASSAY; CANCER INCIDENCE; CELL PROLIFERATION; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY CANCER; KIDNEY INJURY; LABELING INDEX; LIVER CARCINOGENESIS; LIVER CELL; LIVER REGENERATION; MALE; MOUSE; NONHUMAN; OSMOTIC PUMP; PRIORITY JOURNAL;

ANIMALS; BODY WEIGHT; CARCINOGENS; CELL DIVISION; CHLOROFORM; FEMALE; KIDNEY; LIVER; MALE; MICE; NECROSIS; REGENERATION;

ANIMALIA;

EID: 0030606236     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04427-8     Document Type: Article

References (24)

1. 1 mice (abstract). Proceedings of the Fifty-third Annual Meeting of the Japanese Cancer Association. See also Matsushima, T. (1994) An inhalation carcinogenesis study of chloroform: initial report. Japan Bioassay Laboratory, Japan Industrial Safety and Health Association, 2445 Ohshibahara Hirasawa Hando Kanagawa, 257 Japan.
2. 1 mice (abstract). Proceedings of the Fifty-third Annual Meeting of the Japanese Cancer Association. See also Matsushima, T. (1994) An inhalation carcinogenesis study of chloroform: initial report. Japan Bioassay Laboratory, Japan Industrial Safety and Health Association, 2445 Ohshibahara Hirasawa Hando Kanagawa, 257 Japan.
3. [2] National Cancer Institute (1976) Carcinogenesis Bioassay of Chloroform, National Tech. Inform. Service No. PB264018/ AS, NCI, Bethesda, MD.
4. 1 mice, Fund. Appl. Toxicol., 5, 760-769.
5. [4] International Programme on Chemical Safety (1994) Chloroform, Environmental Health Criteria 163, World Health Organization, Geneva.
6. [5] Butterworth, B.E., Conolly, R.B. and Morgan, K.T. (1995) A strategy for establishing mode of action of chemical carcinogens as a guide for approaches to risk assessments, Cancer Lett., 93, 129-146.
7. 1 mice: comparison of administration by gavage in corn oil vs. ad libitum in drinking water, Fundam. Appl. Toxicol., 22, 90-102.
8. 1 mice given chloroform by gavage, Fundam. Appl. Toxicol., 23, 537-543.
9. [8] Templin, M.V., Jamison, K.C., Wolf, D.C., Morgan, K.T. and Butterworth, B.E. (1996) Comparison of chloroform-induced toxicity in the kidneys, liver and nasal passages of male Osborne-Mendel and F-344 rats, Cancer Lett., 104, 71-78.
10. [9] Templin, M.V., Larson, J.L., Butterworth, B.E., Jamison, K.C., Leininger, J.R., Mery, S., Morgan, K.T., Wong, B.A., Conolly, R.B. and Wolf, D.C. (1996) A 90-day chloroform inhalation study in F-344 rats: profile of toxicity and relevance to bioassay results, Fundam. Appl. Toxicol., 32, 109-125.
11. [10] National Institutes of Health (1985) Guide for the Care and Use of Laboratory Animals, United States Department of Health and Human Services, Public Health Service, NIH Publication No. 86-23.
12. 3H]thymidine administered by injection or osmotic pump, Carcinogenesis, 11, 2245-2251.
13. [12] Dorman, D.C., Wong, B.A., Struve, M.F., James, R.A., LaPerle, K.M.D., Marshall, M. and Bolon, B. (1996) Development of a mouse whole-body exposure system from a directed-flow, rat nose-only system, Inhal. Toxicol., 8, 107-120.
14. 1 mice and male F-344 rats, Fundam. Appl. Toxicol., 22, 431-446.
15. [14] Williams, D.A. (1971) A test for differences between treatment means when several dose levels are compared with a zero dose control, Biometrics, 27, 103-117.
16. [15] Williams, D.A. (1972) The comparison of several dose levels with a zero dose control, Biometrics, 28, 519-531.
17. 1 mice: implications for cancer risk assessment, Fundam. Appl. Toxicol., 30, 118-137.
18. [17] Grasso, P. and Hardy, J. (1975) Strain differences in natural incidence and response to carcinogens. In: Mouse Hepatic Neoplasia, pp. 111-131. Editors: W.H. Butler and P.M. Newbeme. Elsevier, NY.
19. [18] Drinkwater, N.R. (1994) Genetic control of hepatocarcinogenesis in C3H mice, Drug Metabol. Rev., 26, 201-208.
20. [19] Lee, G.-H. and Drinkwater, N.R. (1995) Hepatocarcinogenesis in BXH recombinant inbred strains of mice: analysis of diverse phenotypic effects of the hepatocarcinogen sensitivity loci, Mol. Carcinogenesis, 14, 190-197.
21. [20] Hill, R.N., Clemens, T.L., Lui, D.K. and Vesell, E.S. (1975) Genetic control of chloroform toxicity in mice, Science, 190, 159-161.
22. [21] Clemens, T.L., Hill, R.N., Bullock, L.P., Johnson, W.D., Sultatos, L.G. and Vesell, E.S. (1979) Chloroform toxicity in the mouse: role of genetic factors and steroids, Toxicol. Appl. Pharmacol., 48, 117-130.
23. [22] Ahmadizadeh, M., Echt, R., Kuo, C. and Hook, J.B. (1984) Sex and strain differences in mouse kidney: Bowman's capsule morphology and susceptibility to chloroform, Toxicol. Lett., 20, 161-172.
24. [23] Smith, J.H., Maita, K., Sleight, S. and Hook, J.B. (1984) Effect of sex hormone status on chloroform nephrotoxicity and renal mixed function oxidases in mice, Toxicology, 30, 305-316.